These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 10027117)

  • 41. Serotonin receptor and reuptake sites: pharmacologic significance.
    Gonzalez-Heydrich J; Peroutka SJ
    J Clin Psychiatry; 1990 Apr; 51 Suppl():5-12; discussion 13. PubMed ID: 2157701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiogenic syncope and serotonin reuptake inhibitors.
    Kremastinos DT
    Hellenic J Cardiol; 2008; 49(5):375-6. PubMed ID: 18846931
    [No Abstract]   [Full Text] [Related]  

  • 43. Autonomic peripheral vascular dysregulation and mood disorder.
    McMeekin H
    J Affect Disord; 2002 Sep; 71(1-3):277-9. PubMed ID: 12167529
    [No Abstract]   [Full Text] [Related]  

  • 44. Images in clinical medicine. Neurocardiogenic syncope.
    Diehl RR; Linden D
    N Engl J Med; 1998 Jul; 339(5):312. PubMed ID: 9682044
    [No Abstract]   [Full Text] [Related]  

  • 45. A cycle dependent heart - A rare case of menstruation induced neurocardiogenic syncope.
    Azarbal JR; Vargas GA; Davenport J
    Prog Cardiovasc Dis; 2020; 63(3):395. PubMed ID: 32222377
    [No Abstract]   [Full Text] [Related]  

  • 46. Venlafaxine: a novel antidepressant that has a dual mechanism of action.
    Andrews JM; Ninan PT; Nemeroff CB
    Depression; 1996; 4(2):48-56. PubMed ID: 9160640
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A "dysautonomic" head-up tilt test pattern in elderly patients with neurocardiogenic syncope.
    Beck L; Pons M; Piot C; Leclercq F; Messner-Pellenc P; Ferrière M; Davy JM
    Pacing Clin Electrophysiol; 1999 Jul; 22(7):1004-12. PubMed ID: 10456628
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study.
    Theodorakis GN; Leftheriotis D; Livanis EG; Flevari P; Karabela G; Aggelopoulou N; Kremastinos DT
    Europace; 2006 Mar; 8(3):193-8. PubMed ID: 16627439
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tilt methodology in reflex syncope: emerging evidence.
    Fitzpatrick AP; Zaidi A
    J Am Coll Cardiol; 2000 Jul; 36(1):179-80. PubMed ID: 10898431
    [No Abstract]   [Full Text] [Related]  

  • 50. Neurocardiogenic syncope coexisting with postural orthostatic tachycardia syndrome in patients suffering from orthostatic intolerance: a combined form of autonomic dysfunction.
    Kanjwal K; Sheikh M; Karabin B; Kanjwal Y; Grubb BP
    Pacing Clin Electrophysiol; 2011 May; 34(5):549-54. PubMed ID: 21208233
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential effects of the 5-HT2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test.
    Yamada J; Sugimoto Y
    Brain Res; 2002 Dec; 958(1):161-5. PubMed ID: 12468041
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autonomic neuropharmacology.
    Robertson D
    Curr Opin Neurol Neurosurg; 1993 Aug; 6(4):527-30. PubMed ID: 8104552
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clarifications on the effects of 5-HT1A agonists and selective 5-HT reuptake inhibitors on the 5-HT system.
    Blier P; de Montigny C
    Neuropsychopharmacology; 1996 Aug; 15(2):213-6. PubMed ID: 8840358
    [No Abstract]   [Full Text] [Related]  

  • 54. A refractory case of vasovagal syncope treated with theophylline.
    Moore A; Close JC; Jackson SH
    Clin Auton Res; 2003 Aug; 13(4):293-4. PubMed ID: 12955555
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pharma-clinics. How I treat vasovagal syncope].
    Kulbertus H; Melon P
    Rev Med Liege; 1999 Jun; 54(6):510-3. PubMed ID: 10446518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug treatment of orthostatic hypotension because of autonomic failure or neurocardiogenic syncope.
    Lamarre-Cliche M
    Am J Cardiovasc Drugs; 2002; 2(1):23-35. PubMed ID: 14727996
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of vasovagal syncope.
    Atiga WL; Rowe P; Calkins H
    J Cardiovasc Electrophysiol; 1999 Jun; 10(6):874-86. PubMed ID: 10376927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vasovagal syncope and vasovagal disease.
    Brignole M
    Hellenic J Cardiol; 2008; 49(2):61-4. PubMed ID: 18459461
    [No Abstract]   [Full Text] [Related]  

  • 59. [Treatment of recurrent neurocardiogenic syncope with cardiac inhibitors with ipratropium bromide].
    Friederich HC; Michaelsen J; Hesse C; Schellberg D; Schwab M; Herzog W
    Z Kardiol; 2004 Jun; 93(6):479-85. PubMed ID: 15252742
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vasovagal syncope, sympathetic mechanisms and prognosis: the shape of things to come.
    Grassi G
    Eur Heart J; 2010 Aug; 31(16):1951-3. PubMed ID: 20436048
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.